tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HealthEquity price target raised to $120 from $115 at Raymond James

Raymond James analyst C. Gregory Peters raised the firm’s price target on HealthEquity (HQY) to $120 from $115 and keeps a Strong Buy rating on the shares. HealthEquity’s management made considerable progress in Q1 on addressing the fraud activity that plagued the company in the last three quarters, the analyst tells investors in a research note. The firm expects HealthEquity to deliver double digit free cash flow and earnings growth with additional margin expansion through fiscal 2028.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1